News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tengion Inc. Provides Business Update and Reports First Quarter 2013 Financial Results


5/15/2013 7:37:02 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WINSTON-SALEM, N.C., May 15, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the first quarter ended March 31, 2013.

"We are very pleased to have achieved a significant milestone this quarter with the MPA approval for the Phase 1 trial in Sweden of the Neo-Kidney Augment.

Help employers find you! Check out all the jobs and post your resume.

Read at MSN


comments powered by Disqus
MSN
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES